Analytical Wizards Secures Series A Funding to Accelerate Development of Healthcare Analytics Platforms

VCBeat (WeChat ID: vcbeat) learned from foreign media reports that on November 21, 2019, local time, global healthcare analytics company Analytical Wizards announced it had secured Series A financing led by Sopris Capital. The specific amount of this funding round was not disclosed.

Analytical Wizards, headquartered in Edison, New Jersey, USA, is a cutting-edge data science analytics company founded in 2015 by CEO Ram Sharma. Leveraging AI, ML technologies, and domain expertise, Analytical Wizards provides value-driven and business-accelerating solutions to clients in the pharmaceutical and biotechnology industries.

Analytical Wizards offers two proprietary platforms: WIZ—a multi-channel optimization platform, and IZE—real-world study. By leveraging big data processing methods, the company analyzes customer demand for products and employs AI and ML technologies to provide detailed interpretations of such demand analysis.

Jeff Kozloff, CEO of Trial Scope and an active entrepreneur and investor in the healthcare sector, will join the board of directors of Analytical Wizards, alongside Abinav Sankar, Vice President at Sopris Capital, and Jaya Subramaniam, a seasoned executive in the pharmaceutical and biotechnology industries, who will serve as the company’s Chief Strategy Officer.

Analytical Wizards plans to use the funds from this round of financing to support the development of medical products. Currently, Analytical Wizards is allocating part of the raised capital to accelerate the R&D of modules on the IZE platform, aiming to meet the analytical needs of clinical development and HEOR (Health Economics and Outcomes Research) teams, as well as those of commercial brand and sales teams within pharmaceutical or biotechnology companies.

Sopris Capital is a venture capital firm dedicated to providing capital to healthcare and technology-enabled B2B service companies. Sopris Capital works closely with its portfolio companies, assisting them in formulating strategies, building management teams, acquiring customers, and initiating acquisition programs.

Trial Scope is the global leader in clinical trial transparency and compliance. Trial Scope enables clinical trial sponsors to consistently adhere to legal requirements and internal policies, continuously optimize global disclosure processes, effectively track, manage, and respond to clinical data requests, and maintain control and visibility over dynamic disclosure content, processes, and compliance programs.

(Compiled by: Zhao Siyun)